Research & Development

How Can Biopharma Optimize Patient Recruitment in Clinical Trials?
Research & Development How Can Biopharma Optimize Patient Recruitment in Clinical Trials?

Patient recruitment for clinical trials in the biopharma industry is often a challenging task. Successful recruitment strategies can significantly impact the efficiency and effectiveness of clinical trials, ultimately contributing to bringing new therapies to market faster. To achieve this,

How is Constructive Bio Revolutionizing Synthetic Genomics Technology?
Research & Development How is Constructive Bio Revolutionizing Synthetic Genomics Technology?

Biotechnology startup Constructive Bio has recently garnered attention for its innovative advances in synthetic genomics and engineered protein translation. Winning the Innovation Award at the ELRIG Drug Discovery 2024 event highlights the transformative potential of their technologies. This

Zephyrm Targets IPO to Fund Advanced Trials for Cell Therapy ZH901
Research & Development Zephyrm Targets IPO to Fund Advanced Trials for Cell Therapy ZH901

Zephyrm Bioscience has announced its intention to pursue an initial public offering (IPO) on the Hong Kong stock exchange. The biotech company aims to secure significant funding to advance its lead cell therapy candidate, ZH901, into phase 3 clinical trials. ZH901 is targeted at treating both a

AI-Driven Collaboration Enhances Efficiency in Drug Development
Research & Development AI-Driven Collaboration Enhances Efficiency in Drug Development

AI-Driven Collaboration Enhances Efficiency in Drug Development The landscape of drug development is undergoing a transformative shift. Today, advanced technologies like artificial intelligence (AI) are converging with traditional laboratory practices, promising a new era of efficiency and

Excellos and Galapagos Partner to Advance CAR-T Therapy Manufacturing
Research & Development Excellos and Galapagos Partner to Advance CAR-T Therapy Manufacturing

The world of medical and pharmaceutical advancements is frequently marked by innovative partnerships that push the boundaries of what is possible in patient care. One such collaboration has recently emerged between Excellos Inc. and Galapagos. These two entities have teamed up to enhance the

Will Aktis Oncology Lead the Radiopharma Cancer Treatment Revolution?
Research & Development Will Aktis Oncology Lead the Radiopharma Cancer Treatment Revolution?

Boston-based Aktis Oncology is making significant strides in the biopharmaceutical industry, standing out for its innovative efforts in developing radiopharmaceutical medicines aimed at treating cancer. The company recently secured a substantial $175 million in a Series B funding round, designed to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later